SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

HC Wainwright & Co. Maintains Buy on HTG Molecular Diagnostics, Lowers Price Target to $1

HC Wainwright & Co. maintains HTG Molecular Diagnostics (NASDAQ:HTGM) with a Buy and lowers the price target from $1.5 to $1.

Benzinga · 05/14/2020 11:09

HC Wainwright & Co. maintains HTG Molecular Diagnostics (NASDAQ:HTGM) with a Buy and lowers the price target from $1.5 to $1.